IP Library Granted Patent US 10,352,942
Granted Patent B2
US 10,352,942 · App. 15/571,243 · Granted Jul 16, 2019

Correlated peptides for quantitative mass spectrometry

Inventors: Eric Grote (Beverly Hills, CA); Qin Fu (Beverly Hills, CA); Jennifer Van Eyk (Los Angeles, CA); Vidya Venkatraman (Los Angeles, CA)
Assignees: Cedars-Sinai Medical Center; The Johns Hopkins University
G01N33/6848C12Q1/68G01N33/53G01N33/6827G16B30/00G16B40/00G16B99/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,352,942
App. No.
15/571,243
Granted
Jul 16, 2019
Kind
B2
Abstract

Described herein are methods for identifying signature peptides for quantifying a polypeptide of interest in a sample. The methods include cleaving the polypeptide into peptides; detecting a multiplicity of the peptides with a quantitative analytical instrument; comparing the linearity of signals attributable to pairs of the peptides in a multiplicity of samples; and selecting signature peptides from a group of peptides with more highly correlated signals.

Claims (55)

1. A method of identifying signature peptides for quantifying a polypeptide in a sample, comprising:

acquiring mass spectrometry (MS) data on multiple candidate peptides derived from the polypeptide in multiple samples,

wherein acquiring MS data comprises operating a mass spectrometer;

using the MS data to calculate correlation values for pairwise comparisons among the multiple candidate peptides;

eliminating candidate peptides containing a methionine amino acid residue; and

identifying highly correlated peptides among the multiple candidate peptides without methionine,

wherein the highly correlated peptides have mean or median correlation values ranked in the top 80% among the multiple candidate peptides without methionine, and

wherein the highly correlated peptides are identified as the signature peptides for quantifying the polypeptide.

2. The method of claim 1 , wherein the MS data is collected by a targeted acquisition method.

3. The method of claim 1 , wherein the MS data is collected by a data independent acquisition method.

4. The method of claim 1 , wherein the correlation values are coefficient of determination (r 2 ) values.

5. The method of claim 1 , wherein the multiple candidate peptides are derived by proteolysis or chemical cleavage of the polypeptide.

6. The method of claim 1 , wherein the sample is derived from food, water, cheek swab, blood, serum, plasma, urine, saliva, semen, cells, tissue, tumor, or a combination thereof.

7. The method of claim 1 , further comprising ranking the correlation values of the multiple candidate peptides.

8. The method of claim 1 , wherein the highly correlated peptides have mean or median correlation values ranked in the top 70% among the multiple candidate peptides without methionine.

9. The method of claim 1 , wherein the multiple candidate peptides are obtained from a data-dependent MS screen, data-independent MS data, targeted peptides data, MS spectral database, or proteotypic peptide prediction, or a combination thereof.

10. The method of claim 1 , further comprising eliminating candidate peptides that satisfy one or more of the following criteria:

i. not previously detected by MS;

ii. not unique to the polypeptide;

iii. absent from the polypeptide's mature form;

iv. containing an uncleaved protease recognition site;

v. susceptible to post-translational modification (PTM);

vi. containing asparagine and/or cysteine residues;

vii. sensitive to endogenous proteases;

viii. having m/z values lower than an m/z bottom cutoff value;

ix. having m/z values higher than an m/z top cutoff value; and

x. having signal intensities lower than an intensity bottom cutoff value in the acquired MS data.

11. The method of claim 1 , wherein the identified signature peptides have signal intensities more than 20 times the background noise intensity value in the acquired MS data.

12. The method of claim 1 , wherein the highly correlated peptides have mean or median correlation values ranked in the top 60% among the multiple candidate peptides without methionine.

13. The method of claim 1 , wherein the highly correlated peptides have mean or median correlation values ranked in the top 50% among the multiple candidate peptides without methionine.

14. The method of claim 1 , wherein the highly correlated peptides have mean or median correlation values ranked in the top 40% among the multiple candidate peptides without methionine.

15. A method of identifying signature peptides for quantifying a polypeptide in a sample, comprising:

acquiring mass spectrometry (MS) data on multiple candidate peptides derived from the polypeptide in multiple samples,

wherein acquiring MS data comprises operating a mass spectrometer;

using the MS data to calculate correlation values for pairwise comparisons among the multiple candidate peptides;

eliminating candidate peptides containing a methionine amino acid residue;

ranking the mean or median correlation values of the multiple candidate peptides; and

identifying highly correlated peptides among the multiple candidate peptides without methionine,

wherein the highly correlated peptides have mean or median correlation values ranked in the top 10 among the multiple candidate peptides without methionine, and

wherein the highly correlated peptides are identified as the signature peptides for quantifying the polypeptide.

16. The method of claim 15 , wherein the highly correlated peptides have mean or median correlation values ranked in the top 6 among the multiple candidate peptides without methionine.

17. A method of quantifying a polypeptide in a sample, comprising:

acquiring mass spectrometry (MS) data on multiple candidate peptides derived from the polypeptide in multiple samples;

using the MS data to calculate correlation values for pairwise comparisons among the multiple candidate peptides;

eliminating candidate peptides containing a methionine amino acid residue;

identifying highly correlated peptides among the multiple candidate peptides without methionine,

wherein the highly correlated peptides have mean or median correlation values ranked in the top 80% among the multiple candidate peptides without methionine, and

wherein the highly correlated peptides are identified as signature peptides for quantifying the polypeptide;

cleaving the polypeptide in the sample to yield the signature peptides;

analyzing the sample on a mass spectrometer;

detecting MS signals of the signature peptides; and

quantifying the polypeptide based on the detected MS signals of the signature peptides.

18. The method of claim 17 , further comprising spiking the sample with an internal standard and detecting MS signals of the internal standard.

19. The method of claim 18 , wherein the internal standard comprises the signature peptide labeled with a stable isotope.

20. The method of claim 18 , further comprising normalizing the signature peptide's MS signals to the internal standard's MS signals.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2018
From: VENKATRAMAN, VIDYA
To: CEDARS-SINAI MEDICAL CENTER
Reel/Frame 046281/0367 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2018
From: GROTE, ERIC; FU, QIN; VAN EYK, JENNIFER
To: CEDARS-SINAI MEDICAL CENTER; THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 046281/0447 →
CONFIRMATORY LICENSE Recorded Mar 2, 2018
From: CEDARS-SINAI MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045488/0590 →
Continuity (2)
Provisional Application 62168671 · May 29, 2015
Related Publication 20180136220A1 · May 17, 2018
Cited By (1)
US 12,578,346